Pediatric Cancer

PEDIATRIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Does Larotrectinib Offer New Hope to Children With TRK Fusion-Positive Solid Tumors?

Because of the drug’s promising safety and efficacy, the first child was treated on trial only 9 months after the first adult with a TRK fusion was treated.
Recent Conference Highlights New Potential Targets for Pediatric Cancer Treatments

Advances in targeted therapy for pediatric patients were presented at the AACR Special Conference on Pediatric Cancer.

PEDIATRIC CANCER NEWS

While survival rates of pediatric patients with cancer are greatly improved, researchers and clinici

RACE for Children Act Could Substantially Increase Studies of Pediatric Cancer Drugs

March 25, 2020

Expert Opinion on Addressing Psychosocial Needs of Children Receiving CAR-T Therapy

March 23, 2020

Childhood cancer survivors exposed to therapies that cause pulmonary dysfunction are associated with

AAP Addresses Fertility Preservation for Children With Cancer

February 19, 2020

Population-wide care ought to be optimal, regardless of region, argue the authors of a recent study.

Coronary Artery Disease Risk Down in Survivors of Childhood Cancer

January 17, 2020

Population-wide care ought to be optimal, regardless of region, argue the authors of a recent study.

Next-Gen Sequencing Found to Predict Bloodstream Infections in Children

January 6, 2020

Next post in Pediatric Cancer

Long-Term Follow-Up for Late Effects in Survivors of Childhood and Adolescent/Young Adult Cancers

Overall Cancer Survival Rates Up Among Adolescents, Young Adults